Connect with us

Technology

FACTOR X Emerges from Stealth with Novel RNA – based Technology to Transform the Global Beauty Industry

Published

on

FACTOR X is a newly launched longevity-focused beauty technology company developing a breakthrough cellular delivery platform designed to transform the anti-aging skincare industry. Founded by entrepreneur and model Bar Refaeli, longevity physician Dr. Inbal Gat, Harvard-trained scientist Dr. Shira Orr, and health-tech entrepreneur Eran Orr, the company combines world-class scientific expertise with global commercial experience. The company’s proprietary technology enables the precise and safe delivery of active ingredients directly into targeted skin cells, opening the door to next-generation cosmetic products that can stimulate natural hyaluronic acid production, restore hair pigmentation, activate dormant hair follicles, improve skin pigmentation, and support healthier, more youthful skin at the cellular level. Following a successful pre-seed financing round, FACTOR X is currently raising a seed round to accelerate product development, expand strategic partnerships, and establish laboratory operations in Israel alongside its research activities in Boston. The platform is designed for easy integration into existing cosmetic formulations, offering major beauty brands a scalable, room-temperature-stable solution that could redefine the emerging “Skin Longevity” category

TEL AVIV, Israel, July 12, 2026 /PRNewswire-PRWeb/ — FACTOR X, a longevity-focused beauty technology company, today announced its official launch.

Following the successful completion of a pre-seed financing round, the company is now raising a seed round to accelerate development and expand its operations.

FACTOR X was founded by an exceptional team that combines pioneering science, longevity medicine, and global business expertise. The founding team includes international entrepreneur and model Bar Refaeli, longevity physician Dr. Inbal Gat, Harvard-trained scientist Dr. Shira Orr, and serial health-tech entrepreneur Eran Orr.

The company is developing a proprietary cellular delivery platform based on the principles of longevity science that, for the first time, enables the safe and precise delivery of biological payloads such as RNA directly into skin cells. Unlike conventional cosmetic technologies that primarily act on the skin’s surface, FACTOR X aims to fundamentally redefine how anti-aging products work.

The company’s technology combines a proprietary nanoparticle with RNA therapeutics. The nanoparticle protects the RNA as it penetrates the skin and delivers it directly into target cells, where it instructs them to restore youthful biological function. Potential applications include stimulating natural hyaluronic acid production in aging skin, restoring natural hair pigmentation, reactivating dormant hair follicles, reducing pigmentation disorders, and repairing biological aging pathways within skin cells.

FACTOR X was established through the strategic collaboration of three female founders, each contributing unique expertise to transform the global beauty industry.

The company’s clinical vision is led by Dr. Inbal Gat, a physician (DMD) who graduated with Dean’s Honors from Tel Aviv University and became the first Israeli to complete the global longevity medicine program at the American Academy of Anti-Aging Medicine (A4M), earning international certification in functional and longevity medicine. Following more than a decade of clinical practice in aesthetic medicine and extensive research in longevity, Dr. Gat developed her “Skin Longevity” philosophy, combining clinical experience with a deep understanding of the biology of aging.

Joining the team is Dr. Shira Orr, Chief Scientist and Co-Founder, who completed her postdoctoral research at Harvard University. Dr. Orr is leading the development of the company’s proprietary platform, whose nanoparticles transport RNA directly into target skin cells.

Completing the founding team is Bar Refaeli, who brings global visibility, brand recognition, and unparalleled access to international luxury beauty, marketing, media, and distribution networks.

Also joining the leadership team is Eran Orr, Founder and CEO of XRHealth and a recognized serial entrepreneur in digital health and medical devices. XRHealth has raised tens of millions of dollars from international investors and operates one of the world’s leading immersive healthcare platforms.

Dr. Inbal Gat, Co-Founder and Skin Longevity Pioneer

“Throughout my career in aesthetic medicine, I have always searched for ways to rejuvenate the skin from within rather than simply covering it with topical ingredients. FACTOR X applies the most advanced principles of longevity medicine and translates cutting-edge scientific discoveries into products that can communicate directly with skin cells, repair biological dysfunction, and restore youthful cellular activity. That is what true Skin Longevity means.”

Dr. Shira Orr, Co-Founder and Chief Scientific Officer

“Our platform is designed to be completely safe for everyday use, non-toxic, stable as a room-temperature powder, and easily incorporated into virtually any cosmetic formulation. Its precision enables RNA to reach specific target cells such as fibroblasts and stimulate them to produce proteins as they would in biologically younger skin.”

Bar Refaeli, Co-Founder

“Throughout my career, I’ve been exposed to countless beauty products, but FACTOR X represents something fundamentally different. When I learned about the science behind the company, it became clear that this wasn’t simply another cosmetic brand—it is a platform capable of changing the future of the beauty industry. Our vision isn’t to compete with existing brands, but to enable them by integrating our technology into the world’s leading skincare products.”

Currently in the proof-of-concept stage, FACTOR X offers several significant scientific and commercial advantages. Unlike many existing intracellular delivery technologies, which often suffer from toxicity, the FACTOR X platform is designed to be non-toxic and suitable for routine daily use. Its precision targeting allows RNA payloads to reach only intended cells, such as fibroblasts, minimizing off-target effects.

The platform also delivers two major commercial innovations. First, it is stable at room temperature with a long shelf life, eliminating the need for costly cold-chain logistics. Second, the RNA-loaded nanoparticles are manufactured as a stable powder that can be easily incorporated into existing cosmetic products—including creams, serums, and masks—without altering their original formulations.

This capability enables a highly scalable B2B business model, allowing FACTOR X to partner with leading global cosmetics companies without requiring them to redesign existing manufacturing processes, while still preserving the option to develop proprietary consumer products.

Initial proof-of-concept studies have already demonstrated promising technological feasibility. The company is now expanding development efforts and building international strategic partnerships, leveraging the scientific expertise and global reach of its founding team to establish Real Skin Longevity as one of the fastest-growing categories in beauty, longevity, and consumer biotechnology.

Media Contact

Shira Orr, Factor X, 972 9999999, contact@factorx.skin, https://www.factorx.skin/

View original content to download multimedia:https://www.prweb.com/releases/factor-x-emerges-from-stealth-with-novel-rna—based-technology-to-transform-the-global-beauty-industry-302823448.html

SOURCE Factor X

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

CGTN AMERICA & CCTV UN: Kyrgyz Audiences Get Access to Chinese Documentaries, Drama and Cultural Programs in Bishkek Screening Event

Published

on

By

A new series of Chinese documentaries, dramas and cultural programs launched in Kyrgyzstan, bringing stories of Chinese craftsmanship, intangible heritage, traditional medicine and daily life to Central Asian viewers, according to a report from China Media Group (CMG) on Wednesday.

WASHINGTON, Aug. 28, 2026 /PRNewswire-PRWeb/ — (This material is distributed by MediaLinks TV, LLC on behalf of CCTV. Additional information is available at the Department of Justice, Washington, D.C.)

CGTN America & CCTV UN releases “Kyrgyz Audiences Get Access to Chinese Documentaries, Drama and Cultural Programs in Bishkek Screening Event”

A new series of Chinese documentaries, dramas and cultural programs launched in Kyrgyzstan, bringing stories of Chinese craftsmanship, intangible heritage, traditional medicine and daily life to Central Asian viewers, according to a report from China Media Group (CMG) on Wednesday.

The screening event, held in Bishkek, features nearly 10 programs produced by CMG. The content will air through the end of October on Kyrgyzstan’s national broadcaster and other regional media outlets.

The initiative builds on a media cooperation agreement signed between CMG and Kyrgyzstan’s National Television and Radio Broadcasting Corporation last year during the Kyrgyz president’s visit to Beijing. This year marks the 25th anniversary of the Shanghai Cooperation Organization (SCO), with Kyrgyzstan hosting the SCO summit as this year’s rotating chair.

The programs on offer range from short-form cultural features to full-length series. Among them, a food-themed drama follows daily life in a restaurant in northwest China, while documentary series spotlight traditional arts, herbal medicine and Chinese design heritage – content that highlights the diversity of contemporary Chinese storytelling beyond blockbuster films.

CMG has steadily expanded its programming reach across Central Asia in recent years. Previous screening campaigns have placed nearly 20 Chinese programs on regional broadcasters, covering topics from culture to contemporary art. Multiple media outlets from SCO member states are covering the current event, reflecting growing cross-border media collaboration in the region.

Media Contact
Sun, CGTN America, 1 2023931850, distribution@cgtnamerica.com 

View original content:https://www.prweb.com/releases/cgtn-america–cctv-un-kyrgyz-audiences-get-access-to-chinese-documentaries-drama-and-cultural-programs-in-bishkek-screening-event-302862470.html

SOURCE CGTN America

Continue Reading

Technology

Addressing Multi-Subcell Mass Production Challenges | Lead Intelligent’s Integrated Solution Unlocks New Pathways for PV Cost Reduction and Higher Output

Published

on

By

WUXI, China, Aug. 28, 2026 /PRNewswire/ — As the photovoltaic industry accelerates its transition toward thinner wafers and higher-power modules, multi-subcell technology has become a key pathway for next-generation high-efficiency production. By improving power generation efficiency, reducing silicon material consumption, and enhancing module resistance against microcracks and hot spots, multi-subcell enables higher-performance modules without changing existing module dimensions—making it a mainstream technology choice for manufacturers pursuing high-efficiency capacity expansion.

However, transforming this technology from concept into stable mass production remains challenging. Laser slicing processes can introduce fragment risks, edge damage during cutting may accelerate cell degradation, and achieving both high-speed production and precision control in thin-wafer stringing remains difficult. These challenges continue to slow down manufacturers’ capacity expansion plans.

Simplifying the Production Line, Maximizing Manufacturing Efficiency

To address the challenges across scribe, passivation, sorting, and stringing processes, Lead Intelligent has developed a complete turnkey multi-slicing production line solution. By integrating all critical manufacturing steps into a unified equipment platform, the solution enables end-to-end process optimization and eliminates key bottlenecks in high-volume production.

Higher Throughput with Fewer Breakages and Lower Material Loss

The integrated solution combines laser scribe, automated material handling, edge passivation, and testing processes, creating a complete front-end manufacturing workflow designed for high-efficiency PV production.

High Throughput for GW-Scale Manufacturing

The scribe system achieves a single-machine capacity of ≥12,000 full-size wafers per hour, while the multi-subcell sorting system reaches ≥10,000 full-size wafers per hour, fully supporting the throughput requirements of gigawatt-scale photovoltaic manufacturing facilities.

Flexible Processing Architecture Minimizes Breakage Risks

Equipped with multiple vision inspection systems, combined with flexible alignment and handling mechanisms, the solution provides continuous protection throughout wafer processing. By reducing mechanical stress during transfer and positioning, it minimizes wafer breakage and improves production yield from the source.

Process Integration Reduces Edge Degradation

The integrated edge passivation module repairs cutting-induced damage, while interconnected equipment data enables rapid defect tracing and process optimization. This significantly shortens production line commissioning cycles and improves overall manufacturing stability.

Multi-Subcell Stringer

As the core equipment within the integrated production line, the multi-subcell stringer is specifically designed to overcome the key challenges associated with high-volume multi-subcell solar cell production.

High Throughput

With a production capacity of up to 16,000 cells per hour, the system effectively addresses the industry challenge of significant throughput reduction after wafer slicing, enabling manufacturers to maintain high productivity in advanced PV production.

High Precision

Built on a granite base platform and equipped with high-precision linear motors, together with advanced vibration suppression technology, the system achieves highly accurate cell positioning and stable high-speed operation.

Superior Welding Quality

The system integrates a uniform-temperature welding zone with closed-loop temperature control to ensure consistent welding performance. Optional buffering and encapsulation processes enable seamless integration with downstream lamination processes, further improving production continuity.

Four Core Benefits Driving Long-Term Manufacturing Value

Leveraging the combined advantages of integrated production equipment and the PHM (Prognostics and Health Management) intelligent predictive maintenance platform, Lead Intelligent’s multi-subcell turnkey solution creates measurable value for customers across four key dimensions: production capacity, material utilization, equipment operation, and long-term scalability.

Maximizing Production Output and Reducing Equipment Cost per Watt

Through high-speed coordination across the entire production line, the system maintains an overall equipment availability rate of ≥98.5%. With higher output within the same factory footprint, the solution improves production efficiency compared with conventional industry approaches and effectively reduces equipment depreciation costs per watt.

Reducing Material Loss and Improving Silicon Utilization

Through comprehensive soft-contact protection mechanisms and multi-layer visual inspection systems designed to prevent wafer breakage, the solution significantly reduces cell scrap rates and minimizes raw material losses throughout production.

PHM Predictive Maintenance Enables Proactive Equipment Management

Powered by Lead Intelligent’s proprietary PHM intelligent maintenance platform, the solution transforms traditional maintenance models from reactive repair and scheduled servicing into proactive equipment health management. By enabling early fault detection and predictive intervention, the system helps reduce both manual inspection requirements and production downtime costs. The average annual maintenance cost of the stringer system is controlled below RMB 60,000, further improving operational efficiency through digitalized maintenance.

Multi-Technology Compatibility Supports Long-Term Product Evolution

The solution is compatible with thin-wafer manufacturing and various next-generation solar cell technologies, while supporting rapid switching between different multi-subcell formats to accommodate future product upgrades. Through a unified turnkey solution covering equipment, data systems, and after-sales services, Lead Intelligent helps customers avoid complex coordination among multiple suppliers while significantly reducing long-term operation and maintenance management challenges.

Multi-subcell technology has become a critical pathway for reducing the levelized cost of electricity (LCOE) in the photovoltaic industry. However, the complexity of full-process manufacturing integration has prevented many companies from successfully transitioning this technology into stable mass production. As a global provider of intelligent manufacturing solutions for the new energy industry, Lead Intelligent has developed a comprehensive multi-subcell turnkey solution covering scribe, automation, passivation, sorting, stringing, and intelligent maintenance.

By addressing critical manufacturing challenges across the entire value chain—including cutting yield, thin-wafer microcracks, insufficient production capacity, and high maintenance costs—the solution enables photovoltaic manufacturers worldwide to accelerate the deployment of high-efficiency multi-subcell production lines. With integrated capabilities in high throughput, low material loss, and intelligent equipment management, Lead Intelligent continues to support the PV industry’s transition toward higher-quality, lower-cost, and more sustainable manufacturing.

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/addressing-multi-subcell-mass-production-challenges–lead-intelligents-integrated-solution-unlocks-new-pathways-for-pv-cost-reduction-and-higher-output-302862580.html

Continue Reading

Technology

Tetragon Financial Group Limited July 2026 Monthly Factsheet

Published

on

By

LONDON, Aug. 28, 2026 /PRNewswire/ — Tetragon has released its Monthly Factsheet for July 2026.

Please click below to access the Monthly Factsheet.

July 2026 Factsheet

About Tetragon:

Tetragon Financial Group is a Guernsey closed-ended investment company. Its non-voting shares are listed on Euronext in Amsterdam, a regulated market of Euronext Amsterdam N.V., and also traded on the Specialist Fund Segment of the Main Market of the London Stock Exchange. Our investment manager is Tetragon Financial Management LP. Find out more at www.tetragoninv.com/shareholders.

Tetragon’s non-voting shares are subject to restrictions on ownership by U.S. persons and are not intended for European retail investors. Please see: www.tetragoninv.com/shareholders/additional-info/.       

Tetragon Investor Relations:
Yuko Thomas
ir@tetragoninv.com

Press Inquiries:
Prosek Partners
pro-tetragon@prosek.com
U.K. +44 20 3890 9193
U.S. +1 212 279 3115

This release does not contain or constitute an offer to sell or a solicitation of an offer to purchase securities in the United States or any other jurisdiction. The securities of Tetragon have not been and will not be registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States or to U.S. persons unless they are registered under applicable law or exempt from registration. Tetragon does not intend to register any portion of its securities in the United States or to conduct a public offer of securities in the United States. In addition, Tetragon has not been and will not be registered under the U.S. Investment Company Act of 1940, and investors will not be entitled to the benefits of such Act. Tetragon is registered in the public register of the Netherlands Authority for the Financial Markets under Section 1:107 of the Financial Markets Supervision Act as a collective investment scheme from a designated country.      

View original content:https://www.prnewswire.co.uk/news-releases/tetragon-financial-group-limited-july-2026-monthly-factsheet-302861982.html

Continue Reading

Trending